Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sonntag

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Medical and Pediatric Oncology|January 1, 1981
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancerA Goldhirsch, R A Joss, F Cavalli, et al.
The Journal of Urology|March 19, 1999
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factorsD Böhlen, M Borner, R W Sonntag, et al.
Tumori|March 1, 1977
A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinomaF Cavalli, E Hasler, H J Ryssel, et al.
International Journal of Cancer|April 1, 1994
Invasion depth is the most important prognostic factor for transitional-cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapyL Mazzucchelli, M Bacchi, U E Studer, et al.
Schweizerische Medizinische Wochenschrift|July 8, 1980
[Phase-II-study with cis-diamminedichloroplatinum (II) in the treatment of advanced malignant lymphomas]F Cavalli, W F Jungi, R W Sonntag, et al.
Cancer Treatment Reports|September 1, 1979
Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary resultsF Cavalli, W F Jungi, R W Sonntag, et al.
Cancer Treatment Reports|February 1, 1980
Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphomaA Goldhirsch, M Pirovino, R W Sonntag, et al.
Schweizerische Medizinische Wochenschrift|December 31, 1977
[Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)]F Cavalli, L Tschopp, A Gerber, et al.
Cancer|October 1, 1975
A controlled study in the use of combined drug therapy for metastatic breast cancerK W Brunner, R W Sonntag, G Martz, et al.
European Urology|January 1, 1993
Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancerU E Studer, M F Fey, A Calderoni, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Medical and Pediatric Oncology|January 1, 1981
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancerA Goldhirsch, R A Joss, F Cavalli, et al.
The Journal of Urology|March 19, 1999
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factorsD Böhlen, M Borner, R W Sonntag, et al.
Tumori|March 1, 1977
A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinomaF Cavalli, E Hasler, H J Ryssel, et al.
International Journal of Cancer|April 1, 1994
Invasion depth is the most important prognostic factor for transitional-cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapyL Mazzucchelli, M Bacchi, U E Studer, et al.
Schweizerische Medizinische Wochenschrift|July 8, 1980
[Phase-II-study with cis-diamminedichloroplatinum (II) in the treatment of advanced malignant lymphomas]F Cavalli, W F Jungi, R W Sonntag, et al.
Cancer Treatment Reports|September 1, 1979
Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary resultsF Cavalli, W F Jungi, R W Sonntag, et al.
Cancer Treatment Reports|February 1, 1980
Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphomaA Goldhirsch, M Pirovino, R W Sonntag, et al.
Schweizerische Medizinische Wochenschrift|December 31, 1977
[Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)]F Cavalli, L Tschopp, A Gerber, et al.
Cancer|October 1, 1975
A controlled study in the use of combined drug therapy for metastatic breast cancerK W Brunner, R W Sonntag, G Martz, et al.
European Urology|January 1, 1993
Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancerU E Studer, M F Fey, A Calderoni, et al.
Pageof 5